Application of clinical proteomics in diagnosis and management of trauma patients

Injury

Volumn 38, Issue 3, 2007, Pages 263-271

  Alpantaki, Kalliopi ^a   Tsiridis, Eleftherios ^a   Pape, Hans Christoph ^b   Giannoudis, Peter V ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Pittsburg Medical School   (United States)

Author keywords

Pharmacogenomics; Proteomics; Trauma

Indexed keywords

ANTIBIOTIC AGENT; SUXAMETHONIUM;

BIOINFORMATICS; BRAIN INJURY; DATA ANALYSIS; FRACTURE NONUNION; HEAD INJURY; HUMAN; INFECTION; INFLAMMATION; INJURY; LASER CAPTURE MICRODISSECTION; MASS SPECTROMETRY; MULTIPLE TRAUMA; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; SEPSIS; SPINE INJURY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

COMPUTATIONAL BIOLOGY; DATA INTERPRETATION, STATISTICAL; HUMANS; PHARMACOGENETICS; PROTEOMICS; TRAUMATOLOGY; WOUNDS AND INJURIES;

EID: 33847382350     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2006.11.021     Document Type: Review

References (70)

1. Aldred S., Grant M.M., and Griffiths H.R. The use of proteomics for the assessment of clinical samples in research. Clin Biochem 37 11 (2004) 943-952
2. Anderson B.O., and Harken A.H. Multiple organ failure: inflammatory priming and activation sequences promote autogenous tissue injury. J Trauma 30 (1990) S44-S47
3. Baker C.C., Oppenheimer L., Stephens B., et al. Epidemiology of trauma deaths. Am J Surg 140 (1980) 144-150
4. Brenner C., and Duccan D. Oncogenomics, molecular approaches to cancer (2004), John Wiley & Sons, Hoboken, New Jersey p. 128-131
5. Celis J.E., and Olsen E. A qualitative and quantitative protein database approach identifies individual and groups of functionally related proteins that are differentially regulated in simian virus 40 (SV 40) transformed human keratinocytes: an overview of the functional changes associated with the transformed phenotype. Electrophoresis 15 (1994) 309-344
6. Charpentier J., and Mira J.P. Role of host response during severe bacterial infection. Arch Pediatr 8 Suppl. 4 (2001) S689-S696
7. Cipole M.D., Pasquale M.D., and Cerra F.B. Secondary organ dysfunction from clinical perspectives to molecular mediators. Crit Care Clin 9 (1993) 261-297
8. Colantonio D.A., and Chan D.W. The clinical application of proteomics. Clin Chim Acta 357 2 (2005) 151-158
9. Conti A., Sanchez-Ruiz Y., Bachi A., et al. Proteome study of human cerebrospinal fluid following traumatic brain injury indicates fibrinogen degradation products as trauma-associated markers. J Neurotrauma 21 7 (2004) 854-863
10. Craven R.A., Totty N., Harnden P., et al. Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations. Am J Pathol 160 (2002) 815-822
11. Dahmer M.K., Randolph A., Vitali S., and Quasney M.W. Genetic polymorphisms in sepsis. Pediatr Crit Care Med 6 Suppl. 3 (2005) S61-S73
12. Davis B.H. Improved diagnostic approaches to infection/sepsis detection. Expert Rev Mol Diagn 5 2 (2005) 193-207
13. Davis E.G., Eichenberger M.R., Grant B.S., and Polk Jr. H.C. Microsatellite markers of interferon-gamma receptor 1 gene correlates with infection following major trauma. Surgery 128 (2000) 301-305
14. De long W., and Born C.T. Cytokines in patients with polytrauma. Clin Orth Relat Res 422 (2004) 57-65
15. Dorman T., and Faraday N. Do genes variants really explain the heterogenous outcome in sepsis?. Crit Care Med 29 (2001) 684-685
16. Dumler J.S., and Valsamakis A. Molecular diagnostics for existing and emerging infections. Complementary tools for a new era of clinical microbiology. Am J Clin Pathol 112 Suppl. 1 (1999) S33-S39
17. Emmert-Buck M.R., Bonner R.F., Smith P.D., et al. Laser capture microdissection. Science 274 (1996) 998-1001
18. Fang X.M., Schroder S., Hoeft A., et al. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 27 (1999) 1330-1334
19. Fenn J.B., Mann M., Meng C.K., et al. Electrospray ionization for mass spectrometry for large biomolecules. Science 246 4926 (1989) 64-71
20. Fisher G., Schneider E.M., and Moldawer L. CD 64 expression in neutrophils is transiently upregulated in patients with septic shock. Intensive Care Med 27 (2001) 1848-1852
21. Fowler A.A., Hamman R.F., Good J.T., et al. Adult respiratory distress syndrome: risk with common predisposition. An Intern Med 98 (1983) 593-597
22. Freeman B.D., and Buchman T.G. Gene in haystack: tumor necrosis factor polymorphisms and outcome in sepsis. Crit Care Med 28 (2000) 3090-3091
23. Giannoudis P.V. Current concepts of inflammatory response after major trauma: an update. Injury, Int J Care Injured 34 (2003) 397-404
24. Giannoudis P.V., Hildebrand F., and Pape H.C. Inflammatory serum markers in patients with multiple trauma. Can they predict outcome?. J Bone Joint Surg (Br) 86 3 (2004) 313-323
25. Goris J.A., Boekhoerst T.P., Nuytinck J.K., and Gimbrere J.S. Multiple organ failure. Arch Surg 120 (1985) 1109-1115
26. Hausman M.R., and Rinker B. Intractable wounds and infections: the role of impaired vascularity and advanced surgical methods for treatment. Am J Surg 187 (2004) S44-S55
27. Hill A.G., Siegel J., Rounds J., and Wilmore D.W. Metabolic response to interleukin-1: centrally and peripherally mediated. Ann Surg 225 (1997) 246-251
28. Hillered L., Vespa P.M., and Hovda D.A. Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma 22 1 (2005) 3-41
29. Hing K. Bone repair in twenty-first century: biology, chemistry or engineering?. Phil Trans R Soc Lond A 362 (2004) 2821-2850
30. Hintz K.A., Rassias A.J., Wardwell K., et al. Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte haemoglobin scavenger receptor CD163. J Leukoc Biol 72 4 (2002) 711-717
31. Hirsch J., Hansen K.C., Burlingame A.L., and Matthay M.A. Proteomics: current techniques and potential applications to lung disease. Am J Physiol Lung Cell Mol Physiol 287 (2004) 1-23
32. Holmes C., Russell J.A., and Walley K.R. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 124 (2003) 1103-1115
33. Hopf H.W. Molecular diagnostics of injury and repair response in critical illness: what is the future of "monitoring" in the intensive care units?. Crit Care Med 31 Suppl. 8 (2003) S518-S523
34. Kahlke V., Schafmayer C., Schniewind B., et al. Are postoperative complications genetically determined by TNF-beta NcoI gene polymorphism?. Surgery 135 4 (2004) 365-373
35. Karas M., and Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 60 (1988) 2299-2301
36. Kiechle F.L., and Holland-Staley C.A. Genomics, transcriptomics, proteomics, and numbers. Arch Pathol Lab Med 127 9 (2003) 1089-1097
37. Krutchinsky A.N., Kalkum M., and Chait B.T. Automatic identification of proteins with a MALDI-quadrupole ion trap mass spectrometer. Anal Chem 73 (2001) 5066-5077
38. Kuruvilla F.G., Shamji A.F., Sternson S.M., et al. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature 416 (2002) 653-657
39. Li J., Wang C., Kelly J.F., et al. Rapid and sensitive separation of trace level protein digests using microfabricated devices coupled to a quadrupole-time-of-flight mass spectrometer. Electrophoresis 21 (2000) 198-210
40. Lindpaintner K. The impact of pharmacogenetics and pharmacogenomics on drug discovery. Nat Rev Drug Discov 1 (2002) 463-469
41. MacBeath G. Protein microarrays and proteomics. Nat Genet 32 (2002) S526-S532
42. Maurer M.H., Berger C., Wolf M., et al. The proteome of human brain microdialysate. Proteome Sci 1 1 (2003) 7
43. Moller H.J., Aerts H., Gronbaek H., et al. Soluble CD163: a marker molecule for monocyte/macrophage activity in disease. Scand J Clin Lab Invest Suppl 237 (2002) 29-33
44. Nast-Kold D., Aufmonkolk M., Rucholtz S., et al. Multiple organ failure still a major cause of morbidity but not mortality in blunt multiple trauma. J Trauma 51 5 (2001) 835-841
45. Nguyen A., and Yaffe M.B. Proteomics and systems biology approaches to signal transduction in sepsis. Crit Care Med 31 Suppl. l (2003) S1-S6
46. Olson S.A. Pulmonary aspects of treatment of long bone fractures in the polytrauma patient. Clin Orthop Relat Res 422 (2004) 66-70
47. Padubidri A., and Browne Jr. E. Effect of vascular enthothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat. Ann Plast Surg 37 (1996) 604-611
48. Pak C.N.G., Geng L., Kit M., et al. Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection. Pediatr Res 56 (2004) 756-803
49. Pak C.N.G., Karen L., Raymond P.O., et al. Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birth weight infants. Pediatr Res 51 (2002) 296-303
50. Pape H.C., Giannoudis P.V., Krettek C., and Trentz O. Timing of fixation of major fractures in blunt polytrauma: role of conventional indicators in clinical decision making. J Orthop Trauma 19 8 (2005) 551-562
51. Pape H.C., Grimme K., Griensven van M., et al. Impact of intramedullary instrumentation versus damage control for femoral fractures on immunoinflammatory parameters: prospective randomized analysis by the EPOFF study group. Trauma 55 1 (2002) 7-13
52. Pape H.C., Hildebrant F., Pertschy S., et al. Changes in management of femoral shaft fractures in poly trauma patients: from early total care to damage control orthopaedic surgery. J Trauma 53 3 (2002) 452-462
53. Paweletz C.P., Charboneau L., Bichsel V.E., et al. A reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20 (2001) 1981-1989
54. Paweletz C.P., Gillispie J.W., Ornstein D.K., et al. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip. Drug Dev Res 49 (2000) 34-42
55. Petricoin E.F. Clinical applications of proteomics. J Nutr 133 7 (2003) S2476-S2484
56. Petricoin E.F., Zoon K.C., Kohn E.C., et al. Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov 1 (2002) 683-695
57. Plebani M. Proteomics: the next revolution in laboratory medicine?. Clin Chim Acta 24;357 2 (2005) 113-122
58. Roberts C.S., Pape H.C., Jones A.L., Malacani A.L., et al. Damage control orthopaedics: evolving concepts in the treatment of patients who have sustained orthopaedic trauma. Instr Course Lect 54 (2005) 447-462
59. Rubin M.A. Using molecular markers to predict outcome. J Urol 172 (2004) S18-S21
60. Sauaia A., Moore F.A., Moore E.E., et al. Epidemiology of trauma deaths: a reassessment. J Trauma 38 (1995) 185-193
61. Schroder J., Kahle V., and Book M.G. Differences in sepsis: genetically determined?. Shock 14 (2000) 307-313
62. Shen Y., Tolic N., Zhao R., et al. High-throughput proteomics using high-efficiency multiple-capillary liquid chromatography with on-line high-performance ESI FTICR mass spectrometry. Anal Chem 73 (2001) 3011-3021
63. Skillman J.J., Brushnell L.S., Goldman H., et al. Respiratory failure, hypotension, sepsis and jaundice: a clinical syndrome associated with lethal haemorrhage from acute stress ulceration of the stomach. Am J Surg 117 (1969) 523-530
64. Sleigh J., Cursons R., and La Pine M. Detection of bacteraemia in critically ill patients using 16S r DNA polymerase chain reaction and DNA sequencing. Intensive Care Med 27 (2001) 1269-1273
65. Stanilova S.A., Miteva L.D., Karakolev Z.T., and Stefanov C.S. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med 32 2 (2006) 260-266
66. Stassen N.A., Breit C.M., Norfleet L.A., and Polk Jr. H.C. IL-18 promoter polymorphisms correlate with the development of post-injury sepsis. Surgery 134 2 (2003) 351-356
67. Stassen N.A., Leslie-Norfleet L.A., Robertson A.M., et al. Interferon-gamma gene polymorphisms and the development of sepsis in patients with trauma. Surgery 132 2 (2002) 289-292
68. Sutherland A.M., Walley K.R., Manocha S., and Russell J.A. The association of interleukin 6 haplotype clades with mortality in critically ill adults. Arch Intern Med 165 1 (2005) 75-82
69. Tang G.J., Huang S.L., Yien H.W., et al. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 28 8 (2000) 2733-2736
70. Washburn M.P., Ulaszek R., Deciu C., et al. Analysis of quantitative proteomic data generated via multidimensional protein identification technology. Anal Chem 74 (2002) 1650-1657